U.S. Court of Appeals for the Federal Circuit
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
This writing
- Type
- Opinion
- Author
- Alan David Lourie
- Filed
- March 14, 2025
- Case
- Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
- Case status
- Decided
Source The authoring judge was read from the signature line of the court's own published opinion.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 24-2351 Document: 64 Page: 1 Filed: 03/14/2025 United States Court of Appeals for the Federal Circuit ______________________ REGENERON PHARMACEUTICALS, INC., Plaintiff-Appellant v. MYLAN PHARMACEUTICALS INC., AMGEN USA, INC., BIOCON BIOLOGICS INC., CELLTRION, INC., FORMYCON AG, SAMSUNG BIOEPIS CO., Defendants AMGEN INC., Defendant-A…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.